ArticleCase reports in medicine2026
Elbow Metastasis From Primary Lung Adenocarcinoma: A Case Report.
Article in Case reports in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Elbow Metastasis From Primary Lung Adenocarcinoma: A Case Report.Case reports in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is a leading cause of cancer-related death worldwide, with bone metastasis frequently seen in advanced stages and often located in the axial skeleton or proximal long bones. Metastasis to the elbow is extremely rare and poses diagnostic and therapeutic challenges. Case Presentation: We report the case of a 39-year-old male with a history of smoking and recent occupational exposure, presenting with an 8-month history of progressive pain, swelling, and limited mobility in the left elbow. Imaging revealed an osteolytic lesion in the distal humerus, prompting further evaluation. A biopsy confirmed metastatic adenocarcinoma from a primary lung tumor. Following diagnosis, the patient underwent a targeted treatment regimen, including chemotherapy, immunotherapy, and localized radiotherapy for elbow metastasis. After 2 years of treatment, the patient achieved complete oncological remission. Conclusion: This case underscores the potential for positive outcomes in rare presentations of metastatic lung cancer to atypical sites such as the distal humerus. Although bone metastasis in lung cancer usually signals poor prognosis and limited therapeutic options, a personalized, multimodal treatment approach can substantially improve outcomes, even in advanced-stage lung cancer with unusual metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.